Archived News

Dr. Robert Dubois of the National Pharmaceutical Council (NPC) has expressed his concerns about CVS Health’s new service offering that allows

The Trump administration moved Wednesday to give Medicare drug plans more choices in the products they can offer patients, in

Last week, the Centers for Medicare & Medicaid Services (CMS) released its 713-page proposed policy changes and updates for the

Imagine a pharmaceutical market designed by Lewis Carroll’s Mad Hatter. In contrast to almost every other market, he might begin

Disasters like major storms, earthquakes, wildfires, and terrorist actions happen. Pharmacists should have plans in place that allow them to

Representatives from the Community Oncology Alliance (COA) joined other cancer stakeholders and policymakers on Capitol Hill today for a briefing

Too many Americans can’t readily access or afford their prescription drugs. Pharmacy benefit managers (PBMs) play a central role in

(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D)

MADRID (Reuters) – Cancer doctors are widening the net for immunotherapy, a hot new class of drugs that enlist the

Clovis Oncology may be the middle child in the new wave of ovarian cancer treatments, but it’s hoping some new